Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Immuneering Corporation
immuneering.comAI Executive Summary
AI-powered analysis of 8-K filing content
Immuneering Corporation held its Annual Meeting of Stockholders on June 11, 2026, where shareholders voted on proposals including the election of two Class II directors, with 44.5 million shares (68.8% quorum) present. This routine governance event establishes board composition and strategic direction through the next annual meeting.
Key Takeaways
Annual Meeting of Stockholders held on June 11, 2026 with strong quorum of 68.8% of outstanding shares
Two Class II directors were elected during the meeting as part of regular board governance
2 more takeaways
Related Filings (1)
1 more filing from Immuneering Corporation in the last 90 days